UA97360C2 - Антитело к egfl7 и способы его применения - Google Patents

Антитело к egfl7 и способы его применения

Info

Publication number
UA97360C2
UA97360C2 UAA200812195A UAA200812195A UA97360C2 UA 97360 C2 UA97360 C2 UA 97360C2 UA A200812195 A UAA200812195 A UA A200812195A UA A200812195 A UAA200812195 A UA A200812195A UA 97360 C2 UA97360 C2 UA 97360C2
Authority
UA
Ukraine
Prior art keywords
egfl7
antibody
pta
subject
antibodies
Prior art date
Application number
UAA200812195A
Other languages
English (en)
Ukrainian (uk)
Inventor
Вейлань Е
Майке ШМИДТ
Джо-энн ХОНГО
Янь У
Original Assignee
Дженентек, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дженентек, Инк. filed Critical Дженентек, Инк.
Priority claimed from PCT/US2007/064242 external-priority patent/WO2007106915A2/en
Publication of UA97360C2 publication Critical patent/UA97360C2/ru

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Изобретение относится к антителу против домена 7, подобного эпидермальному фактору роста (EGFL7), продуцируемому гибридомой, выбранной из группы РТА-7343, РТА-7344, РТА-7345. Изобретение относится также к фармацевтической композиции, содержащей данное антитело, кодирующему его полинуклеотиду, вектору, клетке-хозяину, способу получения антитела, способу уменьшения или ингибирования ангиогенеза у субъекта, способу повышения эффективности ангиогенезного агента у субъекта, имеющего патологическое состояние.
UAA200812195A 2006-03-16 2007-03-16 Антитело к egfl7 и способы его применения UA97360C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78368606P 2006-03-16 2006-03-16
PCT/US2007/064242 WO2007106915A2 (en) 2006-03-16 2007-03-16 Antibodies to egfl7 and methods for their use

Publications (1)

Publication Number Publication Date
UA97360C2 true UA97360C2 (ru) 2012-02-10

Family

ID=40727139

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200812195A UA97360C2 (ru) 2006-03-16 2007-03-16 Антитело к egfl7 и способы его применения

Country Status (3)

Country Link
CN (1) CN101443359A (ru)
UA (1) UA97360C2 (ru)
ZA (1) ZA200807225B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY33578A (es) * 2010-08-31 2012-03-30 Sanofi Sa PÉPTIDO O COMPLEJO PEPTÍDICO QUE SE UNE A INTEGRINA a(ALFA) Y MÉTODOS Y USOS QUE IMPLICAN A LOS MISMOS
WO2013142961A1 (en) * 2012-03-27 2013-10-03 London Health Sciences Centre Research Inc. Egfl7 targeting and/or binding polypeptides and methods for inhibiting angiogenesis
CN112300284B (zh) * 2020-12-29 2021-04-06 慈达(广州)生物技术有限公司 核酸筛选结合抗体检测用于癌症检测中的用途及其制备的试剂盒

Also Published As

Publication number Publication date
ZA200807225B (en) 2009-11-25
CN101443359A (zh) 2009-05-27

Similar Documents

Publication Publication Date Title
WO2010129609A3 (en) Antibodies and methods of use thereof
SG169988A1 (en) Rnai inhibition of alpha-enac expression
MX361468B (es) Espuma o composicion con viscocidad mejorada que contiene un agente quelante.
WO2010088517A8 (en) Methods and systems for purifying transferring and/or manipulating nucleic acids
MY163193A (en) Process and fluid to improve the permeability of sandstone formations using a chelating agent
TW200714289A (en) Treatment of bone disorders
MY153710A (en) Humanized c-kit antibody
WO2008154249A3 (en) Gene expression markers of tumor resistance to her2 inhibitor treatment
MX2010004219A (es) Agentes de enlace de cd19 y usos de los mismos.
WO2011079902A3 (en) Biological inhibitors of ror1 capable of inducing cell death
WO2009056566A3 (en) Plants having enhanced yield-related traits and a method for making the same
BRPI1007706A2 (pt) anticorpo anti-egfl7, anticorpo biespecífico, ácido nucléico, vetor, célula hospedeira, composição, método para produzir um anticorpo anti-egfl7, método de redução ou inibição da angiogênese em um indivíduo, método de acentuação da eficácia de um agente antiangiogênese em um indivíduo e método de redução ou inibição da perfusão e permeabilidade de um tumor em um indivíduo
MX2009004532A (es) Composiciones y metodos para unir esfingosina-1-fosfato.
ATE533838T1 (de) Verfahren zur verbesserten einführung von dna in bakterienzellen
MX2009008698A (es) Arabinoxilo-oligosacaridos en cerveza.
WO2012005550A3 (ko) 담낭암 치료용 약제학적 조성물 및 이를 이용한 담낭암의 성장, 전이 억제 및 치료 방법
IN2012DN00797A (ru)
WO2012160563A3 (en) Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
WO2010042636A3 (en) Telomerase inhibitors and methods of use thereof
BR112013002738A2 (pt) métodos e compostos para o diagnóstico e o tratamento do câncer
WO2007106915A3 (en) Antibodies to egfl7 and methods for their use
WO2010033586A3 (en) Use of hydroxycarboxylates for water hardness control
WO2010061185A3 (en) Carbonic anhydrase inhibitors for treating dandruff and related disorders
WO2010034006A3 (en) The putative tumor suppressor microrna-101 modulates the cancer epigenome by repressing the polycomb group protein ezh2.
FI20075765A7 (fi) Juusto ja menetelmä sen valmistamiseksi